Candel Therapeutics, Inc. short interest in 2025
In 2025, Candel Therapeutics, Inc.'s disclosed short interest ran from 9.00% of shares outstanding on 15 Jan 2025 to 16.74% on 31 Dec 2025, a change of +7.74 percentage points. The year's high was 16.74% on 31 Dec 2025 and its low 7.31% on 14 Mar 2025, averaging 12.45% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.58 days on 31 Dec 2025. Full history: Candel Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 9.00% (15 Jan 2025)
- End of year
- 16.74% (31 Dec 2025)
- Change
- +7.74 pp
- High
- 16.74% (31 Dec 2025)
- Low
- 7.31% (14 Mar 2025)
- Average
- 12.45%
- Highest days to cover
- 14.58 (31 Dec 2025)
- SEC filings marked
- 10
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 9.00% | 1.73 | results (8-K) |
| 31 Jan 2025 | 8.14% | 2.87 | |
| 14 Feb 2025 | 10.62% | 4.00 | |
| 28 Feb 2025 | 10.27% | 1.62 | |
| 14 Mar 2025 | 7.31% | 4.26 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 9.46% | 3.51 | |
| 15 Apr 2025 | 10.68% | 5.28 | |
| 30 Apr 2025 | 11.41% | 5.91 | |
| 15 May 2025 | 13.16% | 7.21 | 10-Q filed, results (8-K) |
| 30 May 2025 | 12.46% | 5.30 | |
| 13 Jun 2025 | 13.25% | 7.69 | |
| 30 Jun 2025 | 13.93% | 6.33 | |
| 15 Jul 2025 | 13.88% | 5.83 | |
| 31 Jul 2025 | 13.69% | 7.34 | |
| 15 Aug 2025 | 12.28% | 10.65 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 13.24% | 13.78 | |
| 15 Sep 2025 | 13.54% | 8.06 | |
| 30 Sep 2025 | 13.16% | 9.54 | |
| 15 Oct 2025 | 13.61% | 7.69 | results (8-K) |
| 31 Oct 2025 | 13.63% | 10.48 | |
| 14 Nov 2025 | 15.20% | 13.19 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 15.07% | 11.87 | |
| 15 Dec 2025 | 15.17% | 6.63 | |
| 31 Dec 2025 | 16.74% | 14.58 |
See also: Candel Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.